Top

Cost Effectiveness and Resource Allocation

Published in:

01-12-2020 | Ebola Virus | Research

Costs and benefits of early response in the Ebola virus disease outbreak in Sierra Leone

Authors: Klas Kellerborg, Werner Brouwer, Pieter van Baal

Published in: Cost Effectiveness and Resource Allocation | Issue 1/2020

Abstract

Background

The 2014–2016 Ebola virus disease (EVD) outbreak in West Africa was the largest EVD outbreak recorded, which has triggered calls for investments that would facilitate an even earlier response. This study aims to estimate the costs and health effects of earlier interventions in Sierra Leone.

Methods

A deterministic and a stochastic compartment model describing the EVD outbreak was estimated using a variety of data sources. Costs and Disability-Adjusted Life Years were used to estimate and compare scenarios of earlier interventions.

Results

Four weeks earlier interventions would have averted 10,257 (IQR 4353–18,813) cases and 8835 (IQR 3766–16,316) deaths. This implies 456 (IQR 194–841) thousand DALYs and 203 (IQR 87–374) million $US saved. The greatest losses occurred outside the healthcare sector.

Conclusions

Earlier response in an Ebola outbreak saves lives and costs. Investments in healthcare system facilitating such responses are needed and can offer good value for money.

Available only for authorised users

World Health Organization. Ebola situation report–30 March 2016. New York: WHO; 2016.

Elston JW, Moosa AJ, Moses F, Walker G, Dotta N, Waldman RJ, et al. Impact of the Ebola outbreak on health systems and population health in Sierra Leone. J Public Health (Oxf). 2015;38(4):673–8.

Plucinski MM, Guilavogui T, Sidikiba S, Diakite N, Diakite S, Dioubate M, et al. Effect of the Ebola-virus-disease epidemic on malaria case management in Guinea, 2014: a cross-sectional survey of health facilities. Lancet Infect Dis. 2015;15(9):1017–23.CrossRef

UNICEF, of Health M, Sanitation. Sierra Leone Health Facilities Survey 2014: Assessing the Impact of the EVD Outbreak on Sierra Leone’s Health System.

Parpia AS, Ndeffo-Mbah ML, Wenzel NS, Galvani AP. Effects of response to 2014–2015 Ebola outbreak on deaths from malaria, HIV/AIDS, and tuberculosis, West Africa. Emerg Infect Dis. 2016;22(3):433–41.CrossRef

Walker PG, White MT, Griffin JT, Reynolds A, Ferguson NM, Ghani AC. Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis. Lancet Infect Dis. 2015;15(7):825–32.CrossRef

World Health Organization. Ebola response roadmap. Geneva: World Health Organization; 2014. http://www.who.int/csr/resources/publications/ebola/response-roadmap/en/.

Moon BK. Identical letters dated 17 September 2014 from the Secretary-General addressed to the President of the General Assembly and the President of the Security Council. 2014. http://www.securitycouncilreport.org/atf/cf/%7B65BFCF9B-6D27-4E9C-8CD3-CF6E4FF96FF9%7D/S_2014_679.pdf.

WHO. Ebola outbreak 2014—present: how the outbreak and WHO’s response unfolded. Vol. 2016. 2016.

10.

Currie J, Grenfell B, Farrar J. Infectious diseases. Beyond Ebola. Science. 2016;351(6275):815–6.CrossRef

11.

Moon S, Sridhar D, Pate MA, Jha AK, Clinton C, Delaunay S, et al. Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola. Lancet. 2015;386(10009):2204–21.CrossRef

12.

Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, Mbanya JC, McKee M, Moodie R, Nishtar S, Piot P. UN high-level panel on the global response to health crises Protecting humanity from future health crises. Lancet. 2011;378(9789):449–55.CrossRef

13.

CDC. Ebola Surveillance—Guinea, Liberia, and Sierra Leone.

14.

on the Global Response to Health Crises Protecting humanity from future health crises UNH-LP. Protecting humanity from future health crises. 2016.

15.

Tambo E, Ugwu EC, Ngogang JY. Need of surveillance response systems to combat Ebola outbreaks and other emerging infectious diseases in African countries. Infect Dis Poverty. 2014;3:29.CrossRef

16.

Dong F, Xu D, Wang Z, Dong M. Evaluation of Ebola spreading in West Africa and decision of optimal medicine delivery strategies based on mathematical models. Infect Genet Evol. 2015;36:35–40.CrossRef

17.

Fisman D, Khoo E, Tuite A. Early epidemic dynamics of the West African. Ebola outbreak: estimates derived with a simple two-parameter model. PLoS Curr. 2014. https://doi.org/10.1371/currents.outbreaks.89c0d3783f36958d96ebbae.CrossRef

18.

Nishiura H, Chowell G. Early transmission dynamics of Ebola virus disease (EVD), West Africa, March to August 2014. Euro Surveill. 2014;19(36):20894.CrossRef

19.

Rivers CM, Lofgren ET, Marathe M, Eubank S, Lewis BL. Modeling the impact of interventions on an epidemic of Ebola in Sierra Leone and Liberia. PLoS Curr. 2014. https://doi.org/10.1371/currents.outbreaks.4d41fe5d6c05e9df30ddce3.CrossRefPubMedPubMedCentral

20.

Siettos CI, Anastassopoulou C, Russo L, Grigoras C, Mylonakis E. Forecasting and control policy assessment for the Ebola virus disease (EVD) epidemic in Sierra Leone using small-world networked model simulations. BMJ Open. 2016;6(1):e008649.CrossRef

21.

Towers S, Patterson-Lomba O, Castillo-Chavez C. Temporal variations in the effective reproduction number of the 2014 West Africa Ebola outbreak. PLoS Curr. 2014. https://doi.org/10.1371/currents.outbreaks.9e4c4294ec8ce1adad28317.CrossRefPubMedPubMedCentral

22.

White RA, MacDonald E, de Blasio BF, Nygard K, Vold L, Rottingen JA. Projected treatment capacity needs in sierra leone. PLoS Curr. 2015. https://doi.org/10.1371/currents.outbreaks.3c3477556808e44cf41d251.CrossRefPubMedPubMedCentral

23.

Team WHOER. Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. N Engl J Med. 2014;371(16):1481–95.CrossRef

24.

Camacho A, Kucharski AJ, Funk S, Breman J, Piot P, Edmunds WJ. Potential for large outbreaks of Ebola virus disease. Epidemics. 2014;9:70–8.CrossRef

25.

Fisman D, Tuite A. Projected impact of vaccination timing and dose availability on the course of the 2014 west African Ebola epidemic. PLoS Curr. 2014. https://doi.org/10.1371/currents.outbreaks.06e00d0546ad426fed83ff2.CrossRefPubMedPubMedCentral

26.

Kucharski AJ, Camacho A, Flasche S, Glover RE, Edmunds WJ, Funk S. Measuring the impact of Ebola control measures in Sierra Leone. Proc Natl Acad Sci USA. 2015;112(46):14366–71.CrossRef

27.

Barbarossa MV, Denes A, Kiss G, Nakata Y, Rost G, Vizi Z. Transmission dynamics and final epidemic size of Ebola virus disease outbreaks with varying interventions. PLoS ONE. 2015;10(7):e0131398.CrossRef

28.

Evans DK, Goldstein M, Popova A. Health-care worker mortality and the legacy of the Ebola epidemic. Lancet Global Health. 2015;3(8):e439–40.CrossRef

29.

Takahashi S, Metcalf CJ, Ferrari MJ, Moss WJ, Truelove SA, Tatem AJ, et al. Reduced vaccination and the risk of measles and other childhood infections post-Ebola. Science. 2015;347(6227):1240–2.CrossRef

30.

Bolkan HA, Bash-Taqi DA, Samai M, Gerdin M, von Schreeb J. Ebola and indirect effects on health service function in sierra leone. PLoS Curr. 2014. https://doi.org/10.1371/currents.outbreaks.0307d588df619f9c9447f8e.CrossRefPubMedPubMedCentral

31.

Bartsch SM, Gorham K, Lee BY. The cost of an Ebola case. Pathog Glob Health. 2015;109(1):4–9.CrossRef

32.

Kirigia JM, Masiye F, Kirigia DG, Akweongo P. Indirect costs associated with deaths from the Ebola virus disease in West Africa. Infect Dis poverty. 2015;4:44–5.CrossRef

33.

Bank TW. 2014–2015 West Africa Ebola crisis: impact.

34.

Murray CJL, Salomon JA, Mathers CD, Lopez AD. Summary measures of population health : concepts, ethics, measurement and applications. Geneva; 2002. 770 p. http://apps.who.int/iris/handle/10665/42439.

35.

Baltussen R, Taghreed A, Torres TT, Hutubessy R, Acharya A, Evans DB, et al. Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: WHO; 2004.

36.

Team WHOER, Agua-Agum J, Ariyarajah A, Aylward B, Blake IM, Brennan R, et al. West African Ebola epidemic after one year-slowing but not yet under control. N Engl J Med. 2015;372(6):584–7.CrossRef

37.

B K. United Nations General Assembly: Sixty-Ninth Session Agenda Item 124 Global Health and Foreign Policy.

38.

Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2015;388(10053):1545–602. https://doi.org/10.1016/S0140-6736(16)31678-6.CrossRef

39.

Krol M, Brouwer W. How to estimate productivity costs in economic evaluations. Pharmacoeconomics. 2014;32(4):335–44.CrossRef

40.

The World Bank. PovcalNet Consumption and Income Distributions. http://iresearch.worldbank.org/PovcalNet/. Accessed 12 Nov 2016.

41.

Gillespie DT. Exact stochastic simulation of coupled chemical reactions. J Phys Chem. 1977;81:2340–61.CrossRef

42.

Gillespie DT. Approximate accelerated stochastic simulation of chemically reacting systems. J Chem Phys. 2001;115(4):1716–33. https://doi.org/10.1063/1.1378322.CrossRef

43.

Legrand J, Grais RF, Boelle PY, Valleron AJ, Flahault A. Understanding the dynamics of Ebola epidemics. Epidemiol Infect. 2007;135(4):610–21.CrossRef

44.

Lau MSY, Dalziel BD, Funk S, McClelland A, Tiffany A, Riley S, et al. Spatial and temporal dynamics of superspreading events in the 2014–2015 West Africa Ebola epidemic. Proc Natl Acad Sci. 2017;114(9):2337–42.CrossRef

45.

Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol. 2004;78(8):4330–41.CrossRef

46.

Meltzer MI, Atkins CY, Santibanez S, Knust B, Petersen BW, Ervin ED, et al. Estimating the future number of cases in the Ebola epidemic–Liberia and Sierra Leone, 2014–2015. MMWR Suppl. 2014;63(3):1–14.PubMed

47.

Brouwer WB, Koopmanschap MA, Rutten FF. Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel. Health Econ. 1997;6(3):253–9.CrossRef

48.

Shuaib F, Gunnala R, Musa EO, Mahoney FJ, Oguntimehin O, Nguku PM, et al. Ebola virus disease outbreak - Nigeria, July–September 2014. MMWR Morb Mortal Wkly Rep. 2014;63(39):867–72.PubMedPubMedCentral

Title: Costs and benefits of early response in the Ebola virus disease outbreak in Sierra Leone
Authors: Klas Kellerborg
Werner Brouwer
Pieter van Baal
Publication date: 01-12-2020
Publisher: BioMed Central
Keyword: Ebola Virus
Published in: Cost Effectiveness and Resource Allocation / Issue 1/2020
Electronic ISSN: 1478-7547
DOI: https://doi.org/10.1186/s12962-020-00207-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Costs and benefits of early response in the Ebola virus disease outbreak in Sierra Leone

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

Using informative prior based on expert opinion in Bayesian estimation of the transition probability matrix in Markov modelling—an example from the cost-effectiveness analysis of the treatment of patients with predominantly negative symptoms of schizophrenia with cariprazine

Dynamic linkages among economic development, environmental pollution and human health in Chinese

How much the Iranian government spent on disasters in the last 100 years? A critical policy analysis

A comprehensive framework for considering additional unintended consequences in economic evaluation

Health systems efficiency in Eastern Mediterranean Region: a data envelopment analysis

Cost-effectiveness of a novel smartphone application to mobilize first responders after witnessed OHCA in Belgium